Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomes.


Journal

Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952

Informations de publication

Date de publication:
01 2023
Historique:
received: 30 03 2022
accepted: 21 06 2022
pubmed: 29 6 2022
medline: 27 1 2023
entrez: 28 6 2022
Statut: ppublish

Résumé

Pulmonary hypertension (PH) is a common and debilitating medical condition with high mortality. PH research has traditionally focused on pulmonary arterial hypertension and its management in expert PH centres. Other forms of PH such as PH associated with cardiac or respiratory disease are more common, less well-understood and associated with higher mortality. Epidemiology of PH in disadvantaged, remote and rural regions, remains largely undocumented. In this review, we discuss the unique challenges in identifying PH in rural and disadvantaged populations using the Top End region of the Northern Territory of Australia as an example. We propose a simple diagnostic approach, ideally suited to regions where resource allocation is scarce, using clinical skills, echocardiography, and an escalation algorithm. The brief history, epidemiology and current literature on PH are summarised to inform the busy clinicians. We highlight two case examples from the Top End to illustrate the challenges and potential solutions.

Identifiants

pubmed: 35762199
doi: 10.1111/imj.15860
pmc: PMC10087585
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-20

Informations de copyright

© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.

Références

Heart Lung Circ. 2017 Apr;26(4):323-330
pubmed: 27939746
Med J Aust. 2003 Jun 2;178(11):564-7
pubmed: 12765505
Chest. 2007 Aug;132(2):373-9
pubmed: 17400671
Am J Respir Crit Care Med. 2012 Oct 15;186(8):790-6
pubmed: 22798320
Med J Aust. 2020 Aug;213(3):118-123
pubmed: 32632952
Respirology. 2020 Aug;25(8):863-871
pubmed: 31997504
Heart. 2016 May;102 Suppl 2:ii42-8
pubmed: 27053697
Nat Rev Cardiol. 2020 Apr;17(4):195-197
pubmed: 31949305
Cardiovasc Diagn Ther. 2020 Apr;10(2):316-324
pubmed: 32420114
Pulm Circ. 2013 Jan;3(1):89-94
pubmed: 23662179
Aust J Gen Pract. 2019 Jul;48(7):465-471
pubmed: 31256507
Heart. 2012 Dec;98(24):1805-11
pubmed: 22760869
Echocardiography. 2018 Aug;35(8):1085-1096
pubmed: 29676489
Eur Respir J. 2007 Jul;30(1):104-9
pubmed: 17360728
Heart Lung Circ. 2018 Nov;27(11):1368-1375
pubmed: 29029950
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Heart Lung Circ. 2019 Sep;28(9):1351-1364
pubmed: 31109891
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30
pubmed: 16456139
J Am Coll Cardiol. 2019 Jun 4;73(21):2660-2672
pubmed: 31146810
Glob Cardiol Sci Pract. 2020 Apr 30;2020(1):e202014
pubmed: 33150158
Eur Heart J. 2017 Oct 7;38(38):2869-2873
pubmed: 28011705
Int J Cardiol. 2016 Jun 1;212:379-86
pubmed: 27061467
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545972
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177
pubmed: 26837729
Chest. 2011 Aug;140(2):301-309
pubmed: 21330386
Ann Intern Med. 1987 Aug;107(2):216-23
pubmed: 3605900
Respirology. 2019 Feb;24(2):162-170
pubmed: 30180305
Circulation. 1984 Oct;70(4):657-62
pubmed: 6478568
Heart Lung Circ. 2019 Apr;28(4):598-604
pubmed: 29599030
Respir Med. 2007 Mar;101(3):389-98
pubmed: 17222544
J Heart Lung Transplant. 2015 Mar;34(3):273-81
pubmed: 25577563
Heart Lung Circ. 2021 Apr;30(4):507-515
pubmed: 32962944
Eur Respir Rev. 2012 Mar 1;21(123):8-18
pubmed: 22379169
Heart Lung Circ. 2019 Sep;28(9):1427-1435
pubmed: 31272827

Auteurs

Pyi Naing (P)

University of Notre Dame Australia, Fremantle, Western Australia, Australia.
Flinders University, Adelaide, South Australia, Australia.
The Prince Charles Hospital, Brisbane, Queensland, Australia.
Royal Darwin Hospital, Top End Health Service, Darwin, Northern Territory, Australia.
University of Queensland, Brisbane, Queensland, Australia.

Nadarajah Kangaharan (N)

Flinders University, Adelaide, South Australia, Australia.
Royal Darwin Hospital, Top End Health Service, Darwin, Northern Territory, Australia.
Northern Territory (NT) Cardiac Service, Darwin, Northern Territory, Australia.

Gregory M Scalia (GM)

The Prince Charles Hospital, Brisbane, Queensland, Australia.
University of Queensland, Brisbane, Queensland, Australia.

Geoff Strange (G)

University of Notre Dame Australia, Fremantle, Western Australia, Australia.
University of Sydney, Sydney, New South Wales, Australia.
Heart Research Institute, Sydney, New South Wales, Australia.

David Playford (D)

University of Notre Dame Australia, Fremantle, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH